Financial Support in an Underserved and Low-Income Population With Heart Failure
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Jun 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see if giving financial support, in the form of a one-time payment of $500, can help improve the lives of low-income patients who have heart failure. Heart failure is a condition where the heart doesn’t pump blood as well as it should, and it can be stressful, especially for those struggling financially. The study will check if this financial help makes it easier for participants to stick to their medication plans and feel better overall. Participants will fill out surveys about their quality of life and other stress factors and will be randomly assigned to receive either the $500 right away or after one month. After that, their progress will be tracked to see how the financial support affects their health and well-being.
To be eligible for this trial, participants need to be over 18 years old, speak English, and have specific heart issues. They should also be experiencing financial difficulties, such as trouble paying bills or having a low income. Throughout the study, participants will attend follow-up visits at one and two months to see how they are doing. It’s important to know that this study is open to all genders and is currently recruiting participants. If you or someone you know meets these criteria and is looking for support, this trial could provide valuable help and insight.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • English speaking participants who completed SOCIAL-HF study surveys
- • Ejection Fraction \<=40% and eligible for at least one component of GDMT
- • Has at least some difficulty paying monthly bills (Somewhat Difficult and Very Difficult)
- • Annual household income \<130% Federal Poverty Limit
- * Have at least two additional social needs based on the following domains:
- • Cost-related nonadherence
- • Food Insecurity
- • Housing Instability
- • Transportation Difficulty
- • Unemployment
- • Household Crowding: Person/Room Ratio \>1
- • Rent Burden: Rent/Income Ratio \>30%
- • Low social support
- • Interpersonal Violence
- • History of Discrimination
- Exclusion Criteria:
- • Unwilling to return for 1 and 2-month follow-up visits.
- • Currently in jail or prison
- • Primary residence outside Dallas County
- • Legal Blindness
- • Systolic blood pressure \<90 mmHg on screening
- • Contraindications or Intolerance all medications available for therapeutic drug monitoring (metoprolol, losartan, lisinopril, valsartan, and spironolactone)
- • Unable to answer orientation questions.
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Dallas, Texas, United States
Patients applied
Trial Officials
Ambarish Pandey, MD,MSCS
Principal Investigator
UT Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported